Evidence map›Paper›PMID 21093533›Full record

ReviewExperimental hematology2011

Regulation and deregulation of mRNA translation during myeloid maturation.

Arati Khanna-Gupta

Open access · bronzeAbstract readReview
In one paragraph

Review in Experimental hematology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Bone Marrow Failure Syndromes: The Ribosomopathies.Journal of bone marrow research · 2013
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Arati Khanna-GuptaDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Akhannagupta@partners.org
Brigham and Women's Hospital · US

Funding

TRANSCRIPTION FACTORS/ GENETIC SEQUENCES REQUIRED FOR CD34 IN EARLY HEMATOPOIESISP01HL063357 · NHLBI · YALE UNIVERSITY · PI FORGET, BERNARD G · 1999 to 2008
$17.4M
NHLBI NIH HHS P01 HL063357NHLBI NIH HHS P01-HL63357
6 · The paper itself

Abstract

Gene expression in the eukaryotic cell is regulated at a number of levels, including transcription of genomic DNA into messenger RNA (mRNA), nucleocytoplasmic export of mRNA, and translation of the exported mRNA into proteins in the cytoplasm by ribosomes. The role played by epigenetics and transcription factors associated with the control of gene expression in the developing neutrophil has been well documented and appreciated over the years. A wealth of information on the role played by transcription factors in myeloid biology has contributed to our understanding of both normal and abnormal neutrophil development. However, regulation of mRNA translation in myeloid cell maturation is much less well-studied. A better understanding of the translational control of myeloid gene expression may provide important insights into both normal and abnormal myeloid maturation. This review summarizes our current understanding of the regulation of myeloid gene expression at the mRNA translational level.

Indexed as

Cell DifferentiationGene Expression RegulationProtein BiosynthesisAnimalsCCAAT-Enhancer-Binding Protein-alphaHumansMyeloid CellsMyeloid Progenitor CellsCCAAT-Enhancer-Binding Protein-alpha

Identifiers

PMID21093533
PMCPMC3037031
OpenAlexW1978592004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.